This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Elsevier Names Dr. Jim Nolin Editor-in-Chief Of Order Set Solution

Stocks in this article: ENL RUK

PHILADELPHIA, February 27, 2013 /PRNewswire/ --

Nolin brings  24 years of experience in academic and community hospitals as an emergency medicine physician

Elsevier, a world-leading provider of scientific, technical and medical information products and services, has appointed Dr. James Nolin as Editor-in-Chief of InOrderâ„¢, Elsevier's new order set solution. Nolin is responsible for leading content production and medical content strategy.

Prior to joining Elsevier, Nolin served as a Director of Clinical Excellence Informatics for Ascension Health, the country's largest Catholic, non-profit health system, based in St. Louis, MO. While there, Nolin led the development of national order sets for the 80-hospital system. Nolin is board certified in emergency medicine and has practiced 24 years in academic and community hospitals as an emergency medicine physician, including as co-founder of the Department of Emergency Medicine at Cook County Hospital in Illinois.

"At Ascension Health, Jim guided the hospitals' staff through the process of implementing and adopting order sets while developing system and local clinical informatics governance," said Jay Katzen, President of Elsevier's clinical solutions business. "We're looking forward to how his unique experience and expertise will help us continue to grow and advance Elsevier's clinical decision support offerings."

InOrder by Elsevier is an intuitive, cloud-based order set solution that enables physicians, clinicians and informaticists to author, review and manage order sets in a collaborative environment.

"Elsevier is a leader in clinical decision support, and I look forward to being a part of the team that will bring innovative clinical solutions to the marketplace in 2013," Nolin said.

Nolin, based in southwest Michigan, holds a B.A. in physics from Baylor University, an M.D. from Wayne State University School of Medicine in Detroit and completed his emergency medicine residency at the University of Chicago.

To meet Jim Nolin and learn more about InOrder and Elsevier, visit Elsevier's booth #6129 at HIMSS13 ( March 3-7) in New Orleans. A complete list of Elsevier demonstrations and presentations at HIMSS13 is at http://www.clinicaldecisionsupport.com/himss13.

About Elsevier

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs